Brief: Rhythm Pharmaceuticals Q4 Net Income USD -41.621 Million
22/02/2024 12:00
Feb 22 (Reuters) - Rhythm Pharmaceuticals Q4 basic EPS USD -0.7. * Q4 operating income USD -41.265 million * Q4 product revenue USD 24.234 million
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand